Ferkauf Graduate School of Psychology, Yeshiva University, Bronx, NY; Department of Pediatrics, Albert Einstein College of Medicine, Children's Hospital at Montefiore, Bronx, NY.
Ferkauf Graduate School of Psychology, Yeshiva University, Bronx, NY.
J Pediatr. 2019 Nov;214:178-186. doi: 10.1016/j.jpeds.2019.06.003. Epub 2019 Jul 15.
To examine baseline measures of illness-specific panic-fear (ie, the level of anxiety experienced specifically during asthma exacerbations) as a protective factor in pediatric asthma outcomes over a 1-year period.
The sample comprised 267 children (Mexican, n = 188; Puerto Rican, n = 79; age 5-12 years) from a longitudinal observational study conducted in Phoenix, AZ and Bronx, NY. Assessments were done at baseline and 3, 6, 9, and 12 months. The Childhood Asthma Symptom Checklist was administered at baseline to children and caregivers to assess children's illness-specific panic-fear. Asthma outcome variables quantified longitudinally included pulmonary function, the Asthma Control Test, acute healthcare utilization, and medication adherence, measured by devices attached to inhaled corticosteroids.
Child report of illness-specific panic-fear at baseline predicted higher forced expiratory volume in 1 second (FEV) % across 1-year follow-up in Mexican children (β = 0.17, P = .02), better asthma control in Puerto Rican children (β = 0.45, P = .007), and less acute healthcare utilization for asthma in both groups (Mexicans: β = -0.39, P = .03; Puerto Ricans: β = -0.47, P = .02). Caregiver report of child panic-fear predicted higher FEV% in Mexican (β = 0.30; P = .02) and Puerto Rican (β = 0.19; P = .05) children. Panic-fear was not related to medication adherence.
Illness-specific panic-fear had beneficial effects on asthma outcomes in both groups of Latino children. The heightened vigilance associated with illness-specific panic-fear may lead children to be more aware of their asthma symptoms and lead to better strategies for asthma management.
研究特定于疾病的惊恐恐惧(即在哮喘恶化期间经历的特定焦虑水平)作为儿童哮喘结果的保护因素,在为期一年的时间内进行。
该样本包括来自亚利桑那州凤凰城和纽约布朗克斯进行的纵向观察性研究的 267 名儿童(墨西哥裔,n=188;波多黎各裔,n=79;年龄 5-12 岁)。评估在基线和 3、6、9 和 12 个月进行。在基线时向儿童及其照顾者发放儿童哮喘症状检查表,以评估儿童的特定疾病惊恐恐惧。通过附着在吸入性皮质类固醇上的设备测量,纵向量化的哮喘结果变量包括肺功能、哮喘控制测试、急性医疗保健利用和药物依从性。
墨西哥儿童基线时报告的特定疾病惊恐恐惧预测在 1 年随访期间 1 秒用力呼气量(FEV)%更高(β=0.17,P=0.02),波多黎各儿童哮喘控制更好(β=0.45,P=0.007),两组的急性哮喘医疗保健利用减少(墨西哥人:β=-0.39,P=0.03;波多黎各人:β=-0.47,P=0.02)。儿童惊恐恐惧的照顾者报告预测墨西哥(β=0.30;P=0.02)和波多黎各(β=0.19;P=0.05)儿童的 FEV%更高。惊恐恐惧与药物依从性无关。
特定于疾病的惊恐恐惧对两组拉丁裔儿童的哮喘结果都有有益的影响。与特定于疾病的惊恐恐惧相关的高度警惕可能使儿童更加意识到他们的哮喘症状,并导致更好的哮喘管理策略。